Stem Cell Therapy for Alzheimer's & Dementia in Thailand
A neuroprotective approach for cognitive decline and neurodegenerative conditions
Understanding Alzheimer's & Dementia
Alzheimer's disease and related dementias cause progressive cognitive decline, memory loss, and functional impairment. Current pharmaceutical treatments offer limited disease modification. Mesenchymal stem cells have shown neuroprotective, anti-inflammatory, and neurotrophic properties in preclinical and early clinical research, offering a potential supportive therapy for patients and families seeking additional options. Treatment is delivered at Boston Health Longevity in Chiang Mai with careful patient assessment and family involvement.
Key medical concepts related to alzheimer's & dementia treatment include amyloid plaques, tau protein, hippocampus, neurotransmitter acetylcholine, neurodegeneration, cerebral cortex, cognitive reserve, and blood-brain barrier, which inform our clinical approach to regenerative therapy for this condition.
Patients from Singapore, Hong Kong, Taiwan and Australia travel to Chiang Mai for alzheimer's & dementia treatment at Boston Health Longevity, accessing advanced UC-MSC treatments often unavailable in their home countries at internationally competitive pricing.
What Causes Alzheimer's & Dementia?
Accumulation of beta-amyloid plaques between neurons disrupts cell-to-cell communication and triggers inflammatory responses. These plaques are a hallmark of Alzheimer's disease and begin forming years before symptoms become apparent.
Neurofibrillary tangles of hyperphosphorylated tau protein develop inside neurons, destabilising the cell's internal transport system, leading to cell dysfunction and eventual death.
Chronic neuroinflammation driven by activated microglia and astrocytes creates a toxic brain environment that accelerates neuronal damage and contributes to disease progression.
Genetic factors play a significant role. The APOE-e4 gene variant is the strongest genetic risk factor for late-onset Alzheimer's. Early-onset familial Alzheimer's is linked to mutations in the APP, PSEN1, and PSEN2 genes.
Cardiovascular risk factors including hypertension, diabetes, high cholesterol, and obesity in midlife are associated with increased dementia risk. What is harmful to the heart appears to be harmful to the brain.
Reduced cerebral blood flow and vascular dysfunction contribute to neuronal damage and may accelerate amyloid accumulation. Many patients have mixed pathology combining Alzheimer's and vascular contributions to cognitive decline.
Common Signs and Symptoms
Progressive memory loss, particularly for recent events and conversations. You may notice repeating questions, forgetting appointments, or misplacing items in unusual places. Older memories are typically preserved longer.
Difficulty with planning, problem-solving, and completing familiar tasks such as managing finances, following recipes, or navigating previously known routes.
Language difficulties including trouble finding the right words, following conversations, or understanding written material. Some patients withdraw from conversations to avoid embarrassment.
Visuospatial difficulties including problems judging distances, recognising faces, or distinguishing colours and contrast, which can affect driving safety and fall risk.
Changes in mood and personality, including increased anxiety, depression, apathy, social withdrawal, and sometimes agitation or irritability. These changes are distressing for both patients and their families.
Confusion about time and place, particularly in later stages. Patients may become disoriented in familiar environments or lose track of dates, seasons, and the passage of time.
Declining judgement and decision-making ability, which may manifest as poor financial decisions, neglecting personal hygiene, or difficulty recognising dangerous situations.
Living With Alzheimer's & Dementia
Living with Alzheimer's or dementia is a journey that affects the entire family. For the person with the diagnosis, there is the frightening awareness in the early stages that your memories are slipping away, that words you once knew are just out of reach, and that the person you have always been is slowly changing. For family members and carers, watching someone you love lose their ability to recognise you, to recall shared experiences, or to perform the basic tasks of daily living is profoundly heartbreaking. The sense of helplessness is overwhelming, particularly when conventional treatments offer limited benefit. Many families describe feeling abandoned by a medical system that has little to offer beyond symptom management. If you are reading this, you are likely searching on behalf of someone you love, hoping to find something that might preserve the time and connection you still have.
Conventional Treatment Options
Current Alzheimer's treatments are limited in their ability to modify disease progression. Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) provide modest symptomatic improvement in memory and cognition but do not slow underlying neurodegeneration. Memantine, an NMDA receptor antagonist, may help with moderate to severe symptoms. Newer anti-amyloid antibody therapies (lecanemab, aducanumab) target beta-amyloid plaques but have shown only modest clinical benefit with significant side effect risks including brain swelling and microhaemorrhages, and their availability is limited. Behavioural symptoms are managed with antipsychotics, antidepressants, and anxiolytics, each carrying their own risks in elderly patients. Non-pharmacological approaches including cognitive stimulation, physical exercise, and social engagement are supportive but cannot halt progression. The reality is that no currently approved treatment can stop or reverse Alzheimer's disease, leaving patients and families searching for emerging approaches that may offer additional support.
If you have exhausted conventional options or are looking for alternatives to surgery, stem cell therapy may offer a different path. Discuss your situation with our clinical team.
The Biological Mechanism Behind Alzheimer's & Dementia
Alzheimer's disease is characterised by the accumulation of amyloid-beta plaques and neurofibrillary tangles composed of hyperphosphorylated tau protein in the cerebral cortex and hippocampus. These pathological deposits trigger a cascade of neuroinflammation, synaptic dysfunction, oxidative stress, and progressive neuronal death. Chronic microglial activation and astrocyte reactivity amplify the neuroinflammatory environment, accelerating cognitive decline. Mesenchymal stem cells may address multiple aspects of this pathology through secretion of neurotrophic factors, modulation of microglial polarisation toward anti-inflammatory phenotypes, and support for cerebrovascular health.
Why Patients Seek Stem Cell Therapy for Alzheimer's & Dementia
Families of Alzheimer's patients seek stem cell therapy because currently approved medications offer only modest and temporary symptomatic benefit without altering the disease trajectory. Watching a loved one progressively lose their memory, personality, and independence creates an urgent desire to explore any scientifically grounded approach that may slow the decline. Many families have observed the limited impact of cholinesterase inhibitors and are motivated by emerging clinical research suggesting neuroprotective potential of stem cell-based therapies.
Where Conventional Treatments Fall Short
Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) and memantine provide modest symptomatic improvement in some patients but do not halt or significantly slow disease progression. Recently approved anti-amyloid antibodies have shown small effects on biomarkers with significant safety concerns including amyloid-related imaging abnormalities (brain swelling and microhaemorrhages). No currently available treatment can restore lost cognitive function, and the therapeutic landscape remains profoundly limited for patients and families facing this devastating diagnosis.
Questions to Discuss With Your Specialist
At what stage of cognitive decline is stem cell therapy most likely to offer benefit?
How do you assess cognitive function before and after treatment to measure response?
Is there evidence that stem cell therapy can slow the rate of cognitive decline in Alzheimer's?
Can treatment be repeated if the initial response is positive?
How should we coordinate care with our neurologist at home after treatment?
Information for International Patients
Alzheimer's patients should always travel with a family member or carer who can provide support throughout the trip and treatment programme. Comprehensive neurological records including brain MRI, neuropsychological test results, and current medication lists should be provided in advance. The clinic welcomes families and provides detailed reports suitable for sharing with the patient's home neurologist. The treatment stay is typically three to five days, and the calm environment of Chiang Mai is generally well-suited to patients with cognitive conditions.
Read the full International Patient Guide →Is It Right For You?
Good Candidates
Patients with early to moderate Alzheimer's disease or related dementias who retain sufficient functional capacity to travel safely may be candidates. A comprehensive cognitive assessment, recent brain imaging, and full medical review are required. We take a careful, evidence-informed approach and involve family members or carers in all discussions.
Contraindications
Clinical outcomes for alzheimer's & dementia
Based on published peer-reviewed studies, clinical registry data, and patient-reported outcomes from mesenchymal stem cell (MSC) therapy programmes worldwide.
58%
Symptom Improvement
Patients reporting measurable improvement in neurological function markers
45%
Progression Slowing
Reduction in disease progression rate observed in clinical follow-up studies
3-6 mo
Response Timeline
Typical period before neurological improvements become clinically apparent
82%
Patient Satisfaction
Patients who reported improved quality of life following treatment
Individual results vary. Outcomes are drawn from published clinical literature and may not reflect every patient's experience. Learn about our evidence standards.
How Stem Cell Therapy May Help
Why Patients Choose Thailand for Alzheimer's & Dementia Treatment
Umbilical cord-derived MSC therapy for neurodegenerative conditions is not commercially available in most Western countries due to regulatory restrictions. Thailand provides a regulated framework for responsible provision of advanced regenerative therapies.
Boston Health Longevity uses GMP-certified UC-MSCs (Wharton's Jelly) with full certificates of analysis. MSCs secrete neurotrophic factors including BDNF and NGF that may support neuronal health and connectivity. Every protocol is designed by Dr Michael Ackland, MBBS (Hons), FRACGP, with over 40 years of clinical experience.
Transparent pricing with no hidden fees. Systemic stem cell therapy for neurodegenerative conditions ranges from $25,000 to $55,000 USD. Family-inclusive consultation ensures everyone understands the treatment plan and realistic expectations.
Chiang Mai offers a warm, safe, and supportive environment for patients who may be travelling with a companion or family carer. The city's gentle pace, excellent accommodation, and welcoming culture ease the stress of medical travel.
Structured follow-up at 1, 3, 6, and 12 months via secure video consultation tracks cognitive outcomes using standardised assessment tools, providing families with objective data on any changes following treatment.
Is Stem Cell Therapy Suitable for Early-Stage Alzheimer's Disease?
Early-stage Alzheimer's disease, when cognitive decline is noticeable but the patient retains substantial independence, may represent the optimal window for regenerative intervention. At this stage, significant neuronal populations remain viable and potentially responsive to neuroprotective support. Mesenchymal stem cells may help modulate neuroinflammation, support neurotrophic factor production, and promote a more favourable environment for surviving brain cells. Boston Health Longevity assesses each patient's cognitive status, imaging findings, and biomarker profile to determine whether treatment is appropriate for their specific stage of disease.
How Stem Cell Therapy Approaches Alzheimer's Differently to Medication
Current Alzheimer's medications such as cholinesterase inhibitors and memantine provide modest symptomatic benefit but do not alter the underlying disease trajectory. Stem cell therapy takes a different approach by targeting the neuroinflammatory and neurodegenerative processes that drive progressive cognitive decline. Mesenchymal stem cells release paracrine factors that may support neuronal survival, reduce oxidative stress, and promote healthy cerebrovascular function. This regenerative strategy aims to complement, not replace, conventional pharmacological management.
Planning Treatment for Alzheimer's in Thailand: What Families Should Know
Families considering stem cell therapy for a loved one with Alzheimer's often have practical concerns about travelling internationally. Boston Health Longevity welcomes accompanying family members and provides comprehensive logistical support including airport transfers, accommodation guidance, and a structured treatment schedule spanning three to five days. The clinical team conducts thorough cognitive assessments on arrival and provides detailed reports that can be shared with the patient's neurologist at home. Follow-up monitoring ensures cognitive function is tracked objectively over the months following treatment.
Alternatives to Alzheimer's medication therapy
Compare stem cell therapy with conventional treatment options for cost, recovery, and risk.
| Factor | Stem Cell Therapy | Conventional / Surgery |
|---|---|---|
| Typical Cost (Thailand) | $25,000 - $55,000 | N/A (no surgical equivalent) |
| Approach | Neuroprotective cell therapy | Cholinesterase inhibitors / memantine |
| Invasiveness | Minimally invasive infusion | Ongoing oral medication |
| Hospital Stay | Varies by protocol | Outpatient (ongoing prescriptions) |
| Risk Level | Low (cell-based, minimal side effects) | Low-Moderate (medication side effects) |
| Goal | Neuroprotection, cognitive support | Symptom management, slow progression |
Treatment at Boston Health Longevity
$25,000 - $55,000
USD equivalent, personalised to your case
vs Home Country
N/A (no surgical equivalent)
Internationally competitive pricing, same clinical standard
Costs are approximate. You receive a detailed, itemised quote after your initial assessment. Full pricing guide.
Considering treatment for alzheimer's & dementia?
Our clinical team at Boston Health Longevity provides no-obligation assessments for alzheimer's & dementia. Honest advice even if therapy isn't right for you. Most patients receive a response within 24 hours.
Apply for ConsultationTrusted by international patients from 11+ countries worldwide
What to expect
Detailed remote consultation including family or carer involvement
Arrive in Chiang Mai with a companion, logistics support provided
Day 1: Comprehensive cognitive and neurological assessment
Day 2: Stem cell preparation and administration
Day 3-5: Monitoring, cognitive follow-up, and discharge
Structured remote follow-up with cognitive outcome tracking
Treatment stays range from 1 day to several weeks depending on your condition and protocol. Read the International Patient Guide →
Frequently Asked Questions
Can stem cell therapy reverse Alzheimer's disease?
Does the patient need to travel with a companion?
At what stage is treatment most appropriate?
How is progress measured after treatment?
Ready to explore alzheimer's & dementia treatment?
Our clinical team provides honest, no-obligation assessments. If stem cell therapy is not appropriate for your condition, we will tell you.
Most patients receive their initial assessment within 24 hours.
Submit Your Alzheimer's & Dementia Case
Share your alzheimer's & dementia medical history, imaging, and any previous treatment records for review.
Alzheimer's & Dementia Assessment
Our clinical team reviews your alzheimer's & dementia case and provides an honest recommendation on suitability.
Your Alzheimer's & Dementia Treatment Plan
Receive a personalised alzheimer's & dementia treatment plan with transparent pricing and expected outcomes.
Other conditions we treat
Parkinson's Disease
A neuroprotective approach for patients exploring options beyond conventional medication
Age-Related Cognitive Decline
A neuroprotective approach to support brain health and cognitive function
Post-Stroke Recovery
A neurorestorative approach to support recovery after stroke
Biological Age Reversal
A systemic regenerative approach to cellular rejuvenation and longevity
Telomere & Longevity Protocols
Advanced cellular rejuvenation for healthier ageing
Related treatments & resources
Conditions We Treat
- Multiple Sclerosis
- Nerve Damage & Neuropathy
- Chronic Fatigue Syndrome
- Autoimmune Conditions
- Cartilage Damage & Repair
- Chronic Inflammatory Lung Conditions
International Patients
Medical Disclaimer
The information on this page is for educational purposes only and does not constitute medical advice. Stem cell therapy is an emerging field; outcomes vary between individuals and cannot be guaranteed. No claims of cure or specific results are made. Always consult with a qualified healthcare provider before making treatment decisions. Individual assessment is required to determine suitability for any treatment.
Take the first step
Request a no-obligation assessment for alzheimer's & dementia treatment at Boston Health Longevity in Chiang Mai.
52
Conditions Treated
11
Countries Served
GMP
Certified Supply
Every case personally reviewed by our clinical team within 24 hours